Skip to main content
SpringerLink
Log in

Immunoneutralization of prolactin prevents stimulatory feedback of prolactin on hypothalamic neuroendocrine dopaminergic neurons

  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

We have found that exogenous prolactin (PRL) stimulates all three populations of hypothalamic neuroendocrine dopaminergic neurons. In this study, we investigated the effects of immunoneutralization of endogenous PRL on the activity of these neurons. Injection of 17β-estradiol (E2) (20 μg subcutaneously) 10 d after ovariectomy induced a proestrus-like increase in PRL in peripheral plasma the following afternoon. At 1000 h the day after E2 injection, rats received either rabbit antirat PRL antiserum (PRL-AS) (200 μL) or normal rabbit serum (NRS, 200 μL, controls) intraperitoneally. Groups of rats were then decapitated every 2 h from 1100 h to 2100 h. Trunk blood was collected and serum extracted with protein A to remove the PRL-AS/PRL complex, and the remaining free PRL was measured by radio immunoassay. Sites of neuroendocrine dopaminergic nerve terminals, the median eminence (ME), and intermediate and neural lobes of the pituitary gland were excised and stored for determination of dopamine (DA) and 3,4-dihydroxyphenyl acetic acid (DOPAC) concentrations by high-performance liquid chromatography electrochemical detection (EC). In addition, the anterior lobe of the pituitary gland, the locus of DA action, was collected. The concentration of PRL in NRS-treated animals increased by 1500 h, peaked by 1700 h, and returned to low levels by 2100 h. PRL-AS prevented the increase in PRL secretion in response to E2. The turnover of DA (DOPAC:DA ratio; an index of dopaminergic neuronal activity) in the ME of NRS-treated animals increased at 1500 h and rapidly returned to basal levels. Treatment with PRL-AS prevented the increase in DA turnover in the ME. DA turnover in the intermediate lobe increased coincident with the peak of PRL in serum of NRS-treated rats. PRL-AS administration prevented increased DA turnover in the intermediate lobe. The turnover of DA in the neural lobe increased by 1300 h and decreased steadily through 2100 h. However, administration of PRL-AS minimally suppressed the turnover of DA in the neural lobe. Moreover, administration of PRL-AS attenuated the rise of DA in the anterior lobe associated with the waning phase of the E2-induced PRL surge. These results clearly indicate that endogenous PRL regulates its own secretion by activating hypothalamic neuroendocrine dopaminergic neurons.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. DeMaria, J. E., Zelena, D., Vescernyés, M., Nagy, G. M., and Freeman, M. E. (1998). Brain Res. 806, 89–94.

    Article  PubMed  CAS  Google Scholar 

  2. Fuxe, K. and Hokfelt, T. (1966). Acta Physiol. Scand. 66, 245.

    PubMed  CAS  Google Scholar 

  3. Fuxe, K. (1964). Acta Physiol. Scand. 58, 383–384.

    Google Scholar 

  4. Bjorklund, A., Moore, R. Y., Nobin, A., and Stenevi, U. (1973). Brain Res. 51, 171–191.

    Article  PubMed  CAS  Google Scholar 

  5. Goudreau, J. L., Lindley, S. E., Lookingland, K. J., and Moore, K. E. (1992). Neuroendocrinology 56, 100–105.

    PubMed  CAS  Google Scholar 

  6. Goudreau, J. L., Falls, W. M., Lookingland, K. J., and Moore, K. E. (1995). Neuroendocrinology 62, 147–154.

    PubMed  CAS  Google Scholar 

  7. Ben-Jonathan, N. (1985). Endocr. Rev. 6, 564–589.

    PubMed  CAS  Google Scholar 

  8. Ben-Jonathan, N. and Peters, L. L. (1982). Endocrinology 110, 1861–1865.

    PubMed  CAS  Google Scholar 

  9. Murai, I. and Ben-Jonathan, N. (1986). Neuroendocrinology 43, 453–458.

    PubMed  CAS  Google Scholar 

  10. Murai, I., Garris, P. A., and Ben-Jonathan, N. (1989). Endocrinology 124, 2343–2349.

    PubMed  CAS  Google Scholar 

  11. Peters, L. A., Hoefer, M. T., and Ben-Jonathan, N. (1981). Science 213, 659–661.

    Article  PubMed  CAS  Google Scholar 

  12. DeMaria, J. E., Livingstone, J. D., and Freeman, M. E. (1998). Neuroendocrinology 67, 377–383.

    Article  PubMed  CAS  Google Scholar 

  13. DeMaria, J. E., Nagy, G. M., Lerant, A. A., Fekete, M. I. E., Levenson, C. W., and Freeman, M. E. (2000). Endocrinology 141, 366–374.

    Article  PubMed  CAS  Google Scholar 

  14. DeMaria, J. E., Lerant, A., and Freeman, M. E. (1999). Brain Res. 837, 236–241.

    Article  PubMed  CAS  Google Scholar 

  15. Nagy, G. M., DeMaria, J. E., and Freeman, M. E. (1998). Brain Res. 790, 315–317.

    Article  PubMed  CAS  Google Scholar 

  16. Lerant, A., Herman, M. E., and Freeman, M. E. (1996). Endocrinology 137, 3621–3628.

    Article  PubMed  CAS  Google Scholar 

  17. Lerant, A. and Freeman, M. (1997). Neuroendocrinology 65, 436–445.

    PubMed  CAS  Google Scholar 

  18. Chiu, S., Koos, R. D. and Wise, P. M. (1992). Endocrinology 130, 1747–1749.

    Article  PubMed  CAS  Google Scholar 

  19. Chiu, S. and Wise, P. M. (1994). J. Neuroendocrinol. 6, 191–199.

    Article  PubMed  CAS  Google Scholar 

  20. Crumeyrolle-Arias, M., Latouche, J., Jammes, H., Djiane, J., Kelly, P. A., Reymond, M. J., and Haour, F. (1993). Neuroendocrinology 57, 457–466.

    PubMed  CAS  Google Scholar 

  21. Meister, B., Jacobsson, G., and Elde, R. (1992). Acta Physiol. Scand. 146, 533–534.

    Article  PubMed  CAS  Google Scholar 

  22. Muccioli, G. and Di Carlo, R. (1994). Brain Res. 663, 244–250.

    Article  PubMed  CAS  Google Scholar 

  23. Pi, X. J. and Grattan, D. R. (1998). J. Compar. Neurol. 394, 462–474.

    Article  CAS  Google Scholar 

  24. Lerant, A., and Freeman, M. E. (1998). Brain Res. 802, 141–154.

    Article  PubMed  CAS  Google Scholar 

  25. Demarest, K., Riegle, G., and Moore, K. (1984). Neuroendocrinology 38, 467–475.

    PubMed  CAS  Google Scholar 

  26. Demarest, K. T., Duda, N. J., Riegle, G. D., and Moore, K. E. (1983). Brain Res. 272, 175–178.

    Article  PubMed  CAS  Google Scholar 

  27. Demarest, K. T., Moore, K. E., and Riegle, G. D. (1987). Neuroendocrinology 45, 227–232.

    PubMed  CAS  Google Scholar 

  28. Demarest, K. T., Moore, K. E., and Riegle, G. D. (1983). Neuroendocrinology 36, 371–375.

    PubMed  CAS  Google Scholar 

  29. Demarest, K. T., and Moore, K. E. (1981). Neuroendocrinology 33, 230–234.

    PubMed  CAS  Google Scholar 

  30. Gudelsky, G. A. and Porter, J. C. (1980). Endocrinology 106, 526–529.

    PubMed  CAS  Google Scholar 

  31. Hokfelt, T. and Fuxe, K. (1972). Neuroendocrinology 9, 100–122.

    PubMed  CAS  Google Scholar 

  32. Koike, K., Kadowaki, K., Hirota, K., Ohmichi, M., Ikegami, H., Sawada, T., Miyake, A., and Tanizawa, O., (1993). Acta Endocrinol. 129, 548–553.

    PubMed  CAS  Google Scholar 

  33. Lee, Y. S. and Voogt, J. L. (1999). Endocrinology 140, 2159–2166.

    Article  PubMed  CAS  Google Scholar 

  34. Gregerson, K. A., and Selmanoff, M. (1989). J. Neurosci. 8, 2477–2484.

    Google Scholar 

  35. Selmanoff, M. (1985). Endocrinology 116, 1943–1952.

    PubMed  CAS  Google Scholar 

  36. Arita, J. and Kimura, F. (1986). Endocrinology 119, 1666–1672.

    PubMed  CAS  Google Scholar 

  37. Moore, K. E. (1987). Biol. Reprod. 36, 47–58.

    Article  PubMed  CAS  Google Scholar 

  38. Lerant, A., Kanyicska, B., and Freeman, M. E. (1999). Proc. Ann. Mtg. Society for Neuroscience 25, 1186 (abstract).

    Google Scholar 

  39. Demarest, K. T., Riegle, G. D., and Moore, K. E. (1985). Neuroendocrinology 40, 369–376.

    PubMed  CAS  Google Scholar 

  40. Demarest, K. T., Riegle, G. D., and Moore, K. E. (1984). Neuroendocrinology 38, 467–475.

    PubMed  CAS  Google Scholar 

  41. Arbogast, L. A. and Voogt, J. L. (1991). Endocrinology 128, 997–1005.

    PubMed  CAS  Google Scholar 

  42. Hentschel, K., Fleckenstein, A. E., Toney, T. W., Lawson, D. M., Moore, K. E., and Lookingland, K. J. (2000). Brain Res. 852, 28–36.

    Article  PubMed  CAS  Google Scholar 

  43. Demarest, K. T., Riegle, G. D., and Moore, K. E. (1984). Endocrinology 115, 2091–2097.

    PubMed  CAS  Google Scholar 

  44. Lookingland, K., Jarry, H. D., and Moore, K. E. (1987). Brain Res. 419, 303–310.

    Article  PubMed  CAS  Google Scholar 

  45. Lindley, S. E., Gunnet, J. W., Lookingland, K. J., and Moore, K. E. (1990). Brain Res. 506, 133–138.

    Article  PubMed  CAS  Google Scholar 

  46. Cramer, O. M., Parker, R., and Porter, J. C. (1979). Endocrinology 104, 419–422.

    PubMed  CAS  Google Scholar 

  47. Cramer, O. M., Parker, R., and Porter, J. C. (1979). Endocrinology 105, 929–933.

    PubMed  CAS  Google Scholar 

  48. Arbogast, L. A. and Voogt, J. L. (1993). Neuroendocrinology 58, 501–510.

    PubMed  CAS  Google Scholar 

  49. Huang, S. K. and Pan, J. T. (1996). Neuroendocrinology. 64, 208–214.

    PubMed  CAS  Google Scholar 

  50. Carretero, J., Vazquez, R. J., Santos, M., Cacicedo, L., Rubio, M., Sanchez-Franco, F. and Vazquez, R. (1996). Neuropeptides 30, 81–86.

    Article  PubMed  CAS  Google Scholar 

  51. Yuan, Z. F. and Pan, J.-T. (1996). Endocrinology. 137, 4120–4125.

    Article  PubMed  CAS  Google Scholar 

  52. Crowley, W. R., Parker, S. L., Armstrong, W. E., Wang, W., and Grosvenor, C. E. (1991). Neuroendocrinology. 53, 493–502.

    PubMed  CAS  Google Scholar 

  53. Horvath, T. L. (1998). J. Neurosci. 18, 1546–1558.

    PubMed  CAS  Google Scholar 

  54. Arey, B. J., Averill, R. L., and Freeman, M. E. (1989). Endocrinology 124, 119–123.

    PubMed  CAS  Google Scholar 

  55. Arey, B. J. and Freeman, M. E. (1989). Endocrinology 124, 878–883.

    Article  PubMed  CAS  Google Scholar 

  56. Arey, B. J. and Freeman, M. E. (1990). Endocrinology 126, 279–284.

    PubMed  CAS  Google Scholar 

  57. Arey, B. J. and Freeman, M. E. (1992). Endocrinology 131, 736–742.

    Article  PubMed  CAS  Google Scholar 

  58. Arey, B. J. and Freeman, M. E. (1992). Endocrinology, 130, 126–132.

    Article  PubMed  CAS  Google Scholar 

  59. Arey, B. J., Kanyicska, B., and Freeman, M. E. (1991). Neuroendocrinology 53, 35–40.

    PubMed  CAS  Google Scholar 

  60. Kanyicska, B., Lerant, A., and Freeman, M. E. (1998). Endocrinology 139, 5164–5173.

    Article  PubMed  CAS  Google Scholar 

  61. Freeman, M. E. and Sterman, J. R. (1978). Endocrinology 102, 1915–1920.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biological Science, Program in Neuroscience, Florida State University, 208 Biomedical Research Facility, 32306-4340, Tallahassee, FL

    Jamie E. DeMaria &  Marc E. Freeman

  2. Neuroendocrine Research Laboratory, Department of Human Morphology and Embryology, Semmelweis University, Budapest, Hungary

    György M. Nagy

Authors
  1. Jamie E. DeMaria
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. György M. Nagy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marc E. Freeman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marc E. Freeman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

DeMaria, J.E., Nagy, G.M. & Freeman, M.E. Immunoneutralization of prolactin prevents stimulatory feedback of prolactin on hypothalamic neuroendocrine dopaminergic neurons. Endocr 12, 333–337 (2000). https://doi.org/10.1385/ENDO:12:3:333

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/ENDO:12:3:333

Key Words

Search

Navigation